DaVita Inc. (DVA)
NYSE: DVA · Real-Time Price · USD
217.04
+3.68 (1.72%)
At close: Jun 26, 2026, 4:00 PM EDT
218.15
+1.11 (0.51%)
After-hours: Jun 26, 2026, 7:55 PM EDT

Company Description

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States.

The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers.

It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services.

Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016.

DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

DaVita Inc.
DaVita logo
Country United States
Founded 1994
IPO Date Oct 31, 1995
Industry Medical Care Facilities
Sector Healthcare
Employees 78,000
CEO Javier Rodriguez

Contact Details

Address:
2000 16th Street
Denver, Colorado 80202
United States
Phone 720 631 2100
Website davita.com

Stock Details

Ticker Symbol DVA
Exchange NYSE
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000927066
CUSIP Number 23918K108
ISIN Number US23918K1088
Employer ID 51-0354549
SIC Code 8090

Key Executives

Name Position
Javier J. Rodriguez Chief Executive Officer and Executive Director
Joel Ackerman Chief Financial Officer and Treasurer
Kathleen Alyce Waters Chief Legal and Public Affairs Officer
James O. Hearty Chief Compliance Officer
David P. Maughan Chief Operating Officer of DaVita Kidney Care
Christopher Michael Berry CPA Group Vice President and Chief Accounting Officer
Nic Eliason Group Vice President of Investor Relations
Stephanie Hendrickson Chief People Officer
Misha Palecek Chief Transformation Officer of U.S. Kidney Care Business
Dr. Jeffrey Allen Giullian Chief Medical Officer of Kidney Care

Latest SEC Filings

Date Type Title
Jun 17, 2026 11-K Annual report of employee stock purchase, savings and similar plans
Jun 16, 2026 144 Filing
Jun 15, 2026 144 Filing
Jun 15, 2026 144 Filing
Jun 15, 2026 144 Filing
Jun 8, 2026 8-K Current Report
May 15, 2026 144 Filing
May 11, 2026 144 Filing
May 7, 2026 144 Filing
May 6, 2026 144 Filing